Long-acting muscarinic M3 receptor antagonists -: GlaxoSmithKline

被引：5
|
作者：
Norman, Peter [1 ]
机构：
[1] Norman Consulting, Burnham SL1 8JW, Bucks, England
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2006年 / 16卷 / 09期
关键词：
bronchodilator; COPD; M-3; receptor; muscarinic antagonist; urinary incontinence;
D O I：
10.1517/13543776.16.9.1315
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two applications claim a novel class of muscarinic M-3 receptor antagonists and their use as long-acting agents for the treatment of chronic obstructive pulmonary disease. The two applications claim closely related structures with one claiming quaternary amine salts of the tertiary amines claimed in the other. The claimed compounds comprise a biarylmethylamine core with the amino group modified by acylation or sulfonation and a tertiary or quaternary amine coupled to the distal ring of the biaryl system.
引用
收藏
页码：1315 / 1320
页数：6
相关论文
共 50 条
  • [11] Synthesis and optimization of novel and selective muscarinic M3 receptor antagonists
    Kumar, Naresh
    Kaur, Kirandeep
    Aeron, Shelly
    Dharmarajan, Sankaranarayanan
    Silamkoti, Arun D. V.
    Mehta, Anita
    Gupta, Suman
    Chugh, Anita
    Gupta, Jang B.
    Salman, Mohammad
    Palle, Venkata P.
    Cliffe, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5256 - 5260
  • [12] Analogues of oxybutynin as M3 selective muscarinic receptor antagonists.
    Sarma, PKS
    Kumar, N
    Kaur, K
    Chugh, A
    Gupta, S
    Dutt, A
    Gupta, JB
    Mehta, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U58 - U59
  • [13] Characterization of V0162, a new long-acting antagonist at human M3 muscarinic acetylcholine receptors
    Heusler, Peter
    Cussac, Didier
    Naline, Emmanuel
    Tardif, Stephanie
    Clerc, Thierry
    Devillier, Philippe
    PHARMACOLOGICAL RESEARCH, 2015, 100 : 117 - 126
  • [14] SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M3) RECEPTORS
    Broadley, Kenneth J.
    Davies, Robin H.
    Escargueil, Christine
    Lee, Alan T. L.
    Penson, Peter
    Thomas, Eric J.
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2011, 76 (07) : 781 - 801
  • [15] Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (09) : 1091 - 1096
  • [16] Optimizing asthma management: Role of long-acting muscarinic antagonists
    Casale, Thomas B.
    Foggs, Michael B.
    Balkissoon, Ronald C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (03) : 557 - 568
  • [17] Understanding the role of long-acting muscarinic antagonists in asthma treatment
    Muiser, Susan
    Gosens, Reinoud
    van den Berge, Maarten
    Kerstjens, Huib A. M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (04) : 352 - 360
  • [18] Synthesis of novel functionally selective and long-acting muscarinic antagonists
    Mesa, Lilyveth
    Martin, Chelsea
    Boulos, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [19] Inhaled long-acting muscarinic antagonists in asthma - A narrative review
    Papi, Alberto
    Fabbri, Leonardo M.
    Kerstjens, Huib A. M.
    Rogliani, Paola
    Watz, Henrik
    Singh, Dave
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 85 : 14 - 22
  • [20] Discovery of Novel Potent Muscarinic M3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M3 Antagonists
    Xiang, Zuojuan
    Liu, Jun
    Sun, Hongbin
    Wen, Xiaoan
    CHEMMEDCHEM, 2017, 12 (15) : 1173 - 1182
12345